COVID Vaccine and Colquitt Regional Medical Center
Frequently Asked Questions (FAQs)
Q: Am I eligible to receive the COVID-19 vaccine?
A: At this time, in accordance with guidelines set by Georgia Department of Public Health (DPH), vaccines may be administered to those individuals in category 1A. This includes: healthcare workers, residents and staff of long-term care facilities, law-enforcement, firefighters, first responders, and individuals over the age of 65 and their caregivers.
Q: How can I get the vaccine?
A: The Southwest Georgia Health District is offering appointments for the COVID-19 vaccine for individuals that qualify under the 1A designation. You may schedule an appointment by calling 229-352-6567 or visiting www.southwestgeorgiapublichealth.org.
Colquitt Regional is also offering COVID-19 vaccinations. Our ability to provide vaccines is based on the number of doses of vaccines that we have on-hand. Presently, we are offering these vaccines to Colquitt Regional and Sterling Physician Group patients. If you would like to be placed on a list to receive a vaccine as doses become available please contact your primary care provider. NOTE: IF YOU ARE NOT 65 YEARS OF AGE OR OLDER, PLEASE DO NOT PLACE YOURSELF ON OUR VACCINE WAITING LIST AT THIS TIME.
If you are over the age of 65 and do not have a primary care provider you may call the Colquitt Regional COVID-19 Hotline (229-891-9380) to be placed on a waiting list. This hotline is staffed daily from 8:30 am – 5:00 pm.
Q: Why should I consider getting the COVID-19 vaccine?
A: Personal protection – large population trials show 95% clinical effectiveness for the vaccine to prevent disease and greatly lessen the severity of symptoms in the limited people that may still contract the virus despite vaccination.
Decrease transmission – receiving the vaccine will not only protect you, but also others around you, including immediate family, coworkers, and friends. Decreasing transmission equates to saving lives.
Q: How does the vaccine work?
A: The COVID virus has characteristic “spikes” on the surface of the virus, which are actually proteins. The mRNA vaccines from Pfizer and Moderna teach the cells in your body to make these spikes, which then allows your body to learn how to fight off cells that contain the spikes. These vaccines are not the actual virus, which is one of the reasons there are only mild side effects. The vaccine is administered as 2 vaccines, spread 21 to 28 days apart (based on brand). Each dose is given as an IM injection.
Q: How many different forms of the vaccine are currently available?
A: Colquitt Regional received two forms of the COVID-19 vaccine. We have Pfizer and Moderna vaccines.
Q: Which of the vaccines will I receive?
A: This will depend on the vaccine supply we have on hand the day you receive the 1st dose. The 2nd dose will be the same as the first.
Q: Who reviewed and approved the vaccine?
A: Clinical data from Pfizer/BioNTech includes testing on 43,000 patients. The FDA advisory committee approved use of the vaccination after presenting study information to the Vaccines and Related Biological Products Advisory Committee (VRBPAC). After it was approved for use, subsequent endorsement has been issued by the CDC’s Advisory Committee on Immunization Practices (ACIP).
Q: What is an EUA?
A: Emergency Use Authorization, granted by the FDA, is based on compelling medical evidence. This designation allows a product to come to market, but with the disclaimer that it has not gone through the full FDA medication approval process. Several therapies used for the treatment of COVID-19 are also being used under an EUA (remdesivir, bamlanivimab, etc).
Q: Will I still have to wear a mask AFTER I get the vaccine?
A: Yes. In accordance with CDC guidelines, individuals should continue to wear masks in public places, even if they have received the vaccine or have antibodies.
Q: If I have been diagnosed with COVID in the past, or have tested positive for antibodies, should I receive the vaccine?
A: Yes. All patients that have been confirmed to have had COVID-19 should consider the vaccine. It is recommended that individuals wait 90 days after a positive test before receiving a vaccine.
Q: Should I receive the vaccine if I am pregnant or nursing?
A: The vaccine has not been studied extensively with pregnancy, and those who are or could become pregnant or currently breast feeding are encouraged to talk with their healthcare provider. The CDC/ACIP guidance does recommend vaccination among pregnant or nursing women who desire receiving the vaccine. More information can be found here:
Q: Should I trust a vaccine that was produced in only 11 months?
A: Historically, new drugs or vaccines can take up to 6 years for development and test through scientific methods prior to reaching the market. However, the US Government and World Health Organization dedicated unprecedented resources of scientists, labs, and money to accelerate the process. The genome for COVID-19 was already mapped prior to cases arriving in the United States. New technology methods as well as a lack of need for culturing the virus enabled acceleration of vaccine creation. Furthermore, the trials were also accelerated, allowing Phase 2 and 3 human studies to be conducted sooner and given priority review by appropriate medical review panels. Of note, the coronavirus vaccine is not the first vaccine to use an accelerated approval process – other vaccinations have gone through condensed processes in order to help stop the spread and transmission of communicable diseases, most recently the H1N1 flu virus.
Q: What side effects could I experience to the vaccine?
A: Pain at the injection site is the most common side effect. Other, less common side effects included tiredness, headache, muscle pain, chills, joint pain, and fever. Most side effects were reported after the 2nd dose.
Q: Does the vaccine contain fetal embryo cells?
Q: Is there a charge for the vaccine?
A: No. The vaccine is free of charge.